Dr Reddy’s launches generic Ciprodex in US market
NEW DELHI: Dr Reddys Laboratories Ltd on Tuesday announced the launch of a generic version of Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension in the American market, following approval from the US Food and Drug Administration (USFDA). Ciprodexis used in adults and children 6 months of age or older to treat certain types of […]
Sun Pharma launches cancer drug in US market
NEW DELHI: Drug major Sun Pharmaceutical Industries on Monday announced launch of INFUGEM injection, used for treatment of cancer, in the US market. In July 2018, Sun Pharma had received approval from the US health regulator for INFUGEM injection. “INFUGEM (gemcitabine in sodium chloride injection), for intravenous use, is now commercially available in the US,” […]
Dr Reddy’s launches injection for anesthesia and sedation in US market
NEW DELHI: Dr Reddy’s Laboratories Thursday announced the launch of Propofol Injectable Emulsion, used for induction of general anesthesia and sedation in intensive care units, in the US market. Propofol Injectable Emulsion is a therapeutic equivalent generic version of Diprivan (Propofol) Injectable Emulsion,” the company said in a BSE filing. Dr Reddy’s said it uses […]